Ignite Creation Date:
2024-05-06 @ 2:53 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04458857
Status:
COMPLETED
Last Update Posted:
2024-04-15
First Post:
2020-06-22
Brief Title:
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Sponsor:
Organization:
Teva Branded Pharmaceutical Products RD Inc